Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Urinary Bladder Neoplasms 13Glioblastoma 4Brain Neoplasms 3Squamous Cell Carcinoma of Head and Neck 2Sarcoma 2Pancreatic Neoplasms 2Neoplasms 2Melanoma 2Glioma 2Astrocytoma 2Urothelial Carcinoma of the Bladder 1Prostatic Hyperplasia 1Pathologic Complete Response 1Paranasal Sinus Neoplasms 1Oligodendroglioma 1Non-Muscle Invasive Bladder Urothelial Carcinoma 1Non-Muscle Invasive Bladder Neoplasms 1Neuroblastoma 1Nasopharyngeal Carcinoma 1Muscle-invasive Urothelial Cancer of the Bladder 1Mouth Neoplasms 1Lymphoma, Follicular 1Lung Neoplasms 1Laryngeal Neoplasms 1Ganglioneuroblastoma 1Estrogen Receptor Positive Breast Cancer 1Ependymoma 1Craniopharyngioma 1Carcinoma, Non-Small-Cell Lung 1Carcinoma 1

Interventions

Temozolomide 25Magnetic Resonance Spectroscopy 19Etoposide 14Cyclophosphamide 13Radiotherapy 10Filgrastim 10Bevacizumab 10Carboplatin 9Biopsy 8Cisplatin 7X-Rays 6Thiotepa 6Specimen Handling 6Phantoms, Imaging 6Carmustine 6Radiation 5Nuclear Medicine Department, Hospital 5Nivolumab 5Irinotecan 52-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 5sargramostim 4Vincristine 4Peripheral Blood Stem Cell Transplantation 4Methotrexate 4Erlotinib Hydrochloride 4Azacitidine 4etoposide phosphate 3Surgical Procedures, Operative 3Lapatinib 3Granulocyte Colony-Stimulating Factor 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Ependymoma × Transurethral Resection of Bladder × Clear all
NCT02722512 2025-02-18

Trial of Heat Shock Protein Peptide Complex-96 (HSPPC-96) Vaccine

Ann & Robert H Lurie Children's Hospital of Chicago

Phase 1 Terminated
10 enrolled
CNS

Astrocytoma, Ependymoma, Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡